Literature DB >> 11145430

The clonal hierachy in multiple myeloma.

T Rasmussen1, L Jensen, H E Johnsen.   

Abstract

In this report we evaluated the number and phenotype of blood circulating B-cell subsets at different stages of differentiation in 26 patients with newly diagnosed multiple myeloma (MM). In all patients, plasma cells and/or plasma blasts could be identified by flow cytometry with a mean frequency of 1.20% and 0.07%, respectively. In 76.9% of the patients these cells showed aberrant expression mainly of CD56, CD28 and CD117, none of these markers were found on the earlier B-lymphocytes. Clonal B-cells preceding the plasma blast stage were identified by patient specific IgH RT-PCR on sorted B-cell subsets. The clonal cells included the less differentiated CD38+ CD19+ and CD38-/CD19+ subsets. illustrating that the clonal cells are part of an ongoing differentiation process. Further, the presence of CD38-/CD19+ cells with somatically mutated Cgamma transcripts identical to the tumor-specific Calpha transcript, shows that the clonal hierarchy in myeloma may include memory B-cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11145430     DOI: 10.1080/028418600750063479

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  10 in total

Review 1.  Cancer stem cells in multiple myeloma.

Authors:  Nilanjan Ghosh; William Matsui
Journal:  Cancer Lett       Date:  2008-09-21       Impact factor: 8.679

Review 2.  The bone marrow stroma in hematological neoplasms--a guilty bystander.

Authors:  Claudio Tripodo; Sabina Sangaletti; Pier P Piccaluga; Sonam Prakash; Giovanni Franco; Ivan Borrello; Attilio Orazi; Mario P Colombo; Stefano A Pileri
Journal:  Nat Rev Clin Oncol       Date:  2011-03-29       Impact factor: 66.675

Review 3.  The myeloma stem cell concept, revisited: from phenomenology to operational terms.

Authors:  Hans Erik Johnsen; Martin Bøgsted; Alexander Schmitz; Julie Støve Bødker; Tarec Christoffer El-Galaly; Preben Johansen; Peter Valent; Niklas Zojer; Els Van Valckenborgh; Karin Vanderkerken; Mark van Duin; Pieter Sonneveld; Martin Perez-Andres; Alberto Orfao; Karen Dybkær
Journal:  Haematologica       Date:  2016-11-10       Impact factor: 9.941

4.  Identification of translocation products but not K-RAS mutations in memory B cells from patients with multiple myeloma.

Authors:  Thomas Rasmussen; Jacob Haaber; Inger Marie Dahl; Lene M Knudsen; Gitte B Kerndrup; Marianne Lodahl; Hans E Johnsen; Michael Kuehl
Journal:  Haematologica       Date:  2010-05-29       Impact factor: 9.941

5.  Rare KIT (CD117) expression in multiple myeloma abrogates the usefulness of imatinib mesylate treatment.

Authors:  A Lugli; P Went; B Khanlari; Z Nikolova; S Dirnhofer
Journal:  Virchows Arch       Date:  2003-12-16       Impact factor: 4.064

Review 6.  Multiple myeloma cancer stem cells.

Authors:  Carol Ann Huff; William Matsui
Journal:  J Clin Oncol       Date:  2008-06-10       Impact factor: 44.544

7.  A multiple myeloma classification system that associates normal B-cell subset phenotypes with prognosis.

Authors:  Julie Støve Bødker; Rasmus Froberg Brøndum; Alexander Schmitz; Anna Amanda Schönherz; Ditte Starberg Jespersen; Mads Sønderkær; Charles Vesteghem; Hanne Due; Caroline Holm Nørgaard; Martin Perez-Andres; Mehmet Kemal Samur; Faith Davies; Brian Walker; Charlotte Pawlyn; Martin Kaiser; David Johnson; Uta Bertsch; Annemiek Broyl; Mark van Duin; Rajen Shah; Preben Johansen; Martin Agge Nørgaard; Richard J Samworth; Pieter Sonneveld; Hartmut Goldschmidt; Gareth J Morgan; Alberto Orfao; Nikhil Munshi; Hans Erik Johnson; Tarec El-Galaly; Karen Dybkær; Martin Bøgsted
Journal:  Blood Adv       Date:  2018-09-25

8.  Validation and implementation of a method for microarray gene expression profiling of minor B-cell subpopulations in man.

Authors:  Kim Steve Bergkvist; Mette Nyegaard; Martin Bøgsted; Alexander Schmitz; Julie Støve Bødker; Simon Mylius Rasmussen; Martin Perez-Andres; Steffen Falgreen; Anders Ellern Bilgrau; Malene Krag Kjeldsen; Michael Gaihede; Martin Agge Nørgaard; John Bæch; Marie-Louise Grønholdt; Frank Svendsen Jensen; Preben Johansen; Karen Dybkær; Hans Erik Johnsen
Journal:  BMC Immunol       Date:  2014-01-31       Impact factor: 3.615

Review 9.  Implications of heterogeneity in multiple myeloma.

Authors:  Sanjay de Mel; Su Hong Lim; Moon Ley Tung; Wee-Joo Chng
Journal:  Biomed Res Int       Date:  2014-07-02       Impact factor: 3.411

Review 10.  Stem cells and bone diseases: new tools, new perspective.

Authors:  Mara Riminucci; Cristina Remoli; Pamela G Robey; Paolo Bianco
Journal:  Bone       Date:  2014-09-18       Impact factor: 4.398

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.